Absci (ABSI) Change in Account Payables (2020 - 2026)
Absci (ABSI) reported Change in Account Payables of -$2.0 million for Q1 2026, up 6.46% on a YoY basis from -$1.9 million in Q1 2025, and down 5613.51% sequentially from $37000.0 in Q4 2025.
Absci (ABSI) Change in Account Payables (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Change in Account Payables data on file, last reported at -$2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 6.46% year-over-year to -$2.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 305.83% YoY), and the FY2025 full-year result was $1.1 million, down 36.8% from the prior year.
- Change in Account Payables eased to -$2.0 million in Q1 2026, from $37000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.8 million in Q2 2025 to a low of -$3.6 million in Q3 2025.
- A 5-year average of -$31411.8 and a median of $22000.0 in 2022 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 16607.32% in 2025, while the deepest fall reached 11940.0% in 2025.
- Tracing ABSI's Change in Account Payables over 5 years: stood at $691000.0 in 2022, then slumped by 158.76% to -$406000.0 in 2023, then soared by 486.7% to $1.6 million in 2024, then plunged by 97.64% to $37000.0 in 2025, then slumped by 5613.51% to -$2.0 million in 2026.
- Business Quant data shows ABSI's Change in Account Payables at -$2.0 million in Q1 2026, $37000.0 in Q4 2025, and -$3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.04 Mn |
| Mar 31, 2026 | -2.04 Mn |
| Dec 31, 2025 | 37,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | -3.61 Mn |
| Sep 30, 2025 | -3.61 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | -2.18 Mn |
| Mar 31, 2025 | -2.18 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | -406,000.00 |
| Dec 31, 2023 | -406,000.00 |